How much funding has Magenta Therapeutics raised?

Magenta Therapeutics has raised $150.5M in total funding, most recently a Series C round.

Who are Magenta Therapeutics's investors?

Magenta Therapeutics's investors include Atlas Venture, Third Rock Ventures, Casdin Capital, GV, EcoR1 Capital, Eventide Asset Management.

When was Magenta Therapeutics founded?

Magenta Therapeutics was founded in 2016.

Where is Magenta Therapeutics headquartered?

Magenta Therapeutics is headquartered in Cambridge, United States.

What industry is Magenta Therapeutics in?

Magenta Therapeutics operates in Biotech, Therapeutics.

How many employees does Magenta Therapeutics have?

Magenta Therapeutics has 51-200 employees.

Magenta Therapeutics

Acquired

2025년 최신 피망머니상 시세표 총정리

Cambridge, United States · Founded 2016 · $150.5M raised

Biotech

Therapeutics

Headquarters: Cambridge
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: magentatx.com
Total Funding: $150.5M
Last Round: $52.0M Series CApr 2018
Rounds: 3

About

Magenta Therapeutics was a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplantation to patients with blood cancers, autoimmune diseases, and genetic disorders. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company merged with Dianthus Therapeutics in 2023.

Summary

Magenta Therapeutics is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $150.5M in total across 3 rounds, most recently a $52.0M Series C round in Apr 2018. Investors include Atlas Venture, Third Rock Ventures and Casdin Capital.